NASDAQ:TACT - TransAct Technologies Stock Price, News, & Analysis

TransAct Technologies trades on the NASDAQ under the ticker symbol "TACT."

TransAct Technologies declared a quarterly dividend on Wednesday, May 1st. Shareholders of record on Monday, May 20th will be given a dividend of $0.09 per share on Friday, June 14th. This represents a $0.36 annualized dividend and a dividend yield of 3.11%. The ex-dividend date is Friday, May 17th. View TransAct Technologies' Dividend History.

TransAct Technologies declared that its Board of Directors has approved a share buyback program on Tuesday, March 6th 2018, which permits the company to repurchase $5,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase programs are often an indication that the company's board believes its shares are undervalued.

TransAct Technologies Incorporated (NASDAQ:TACT) announced its earnings results on Tuesday, May, 7th. The technology company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.05 by $0.05. The technology company had revenue of $11.55 million for the quarter. TransAct Technologies had a net margin of 10.19% and a return on equity of 20.55%. View TransAct Technologies' Earnings History.

TransAct Technologies is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for TransAct Technologies.

1 brokerages have issued 12 month price objectives for TransAct Technologies' shares. Their forecasts range from $14.00 to $14.00. On average, they anticipate TransAct Technologies' stock price to reach $14.00 in the next year. This suggests a possible upside of 21.0% from the stock's current price. View Analyst Price Targets for TransAct Technologies.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TransAct Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for TransAct Technologies.

Media headlines about TACT stock have trended neutral recently, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. TransAct Technologies earned a daily sentiment score of 0.2 on InfoTrie's scale. They also gave media headlines about the technology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for TransAct Technologies.

TransAct Technologies saw a decline in short interest in May. As of May 15th, there was short interest totalling 15,900 shares, a decline of 15.4% from the April 15th total of 18,800 shares. Based on an average daily volume of 18,700 shares, the days-to-cover ratio is currently 0.9 days. Approximately 0.2% of the company's stock are sold short. View TransAct Technologies' Current Options Chain.

Some companies that are related to TransAct Technologies include Immersion (IMMR), AstroNova (ALOT), RADCOM (RDCM), Identiv (INVE), Key Tronic (KTCC), Top Image Systems (TISA), Interlink Electronics (LINK), IGO (IGOI) and Hauppauge Digital (HAUP).

Based on aggregate information from My MarketBeat watchlists, some companies that other TransAct Technologies investors own include Allena Pharmaceuticals (ALNA), REDHILL BIOPHAR/S (RDHL), Veru (VERU), Viking Therapeutics (VKTX), Palatin Technologies (PTN), Cerecor (CERC), Genocea Biosciences (GNCA), Sorrento Therapeutics (SRNE), Viewray (VRAY) and SEASPAN CORP/SH SH (ssw).

TransAct Technologies' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Cowen Prime Services LLC (3.34%), North Star Investment Management Corp. (1.59%), Teton Advisors Inc. (1.56%), Acadian Asset Management LLC (0.85%), Wedge Capital Management L L P NC (0.49%) and Gabelli Funds LLC (0.34%). Company insiders that own TransAct Technologies stock include Andrew John Hoffman, Bart C Shuldman, David B Peters, Graham Y Tanaka, Haydee Olinger, John Dillon, Steven A Demartino, Thomas R Schwarz and Tracey S Chernay. View Institutional Ownership Trends for TransAct Technologies.

TACT stock was sold by a variety of institutional investors in the last quarter, including Cowen Prime Services LLC, Acadian Asset Management LLC, Gabelli Funds LLC, O Shaughnessy Asset Management LLC and Teton Advisors Inc.. Company insiders that have sold TransAct Technologies company stock in the last year include Bart C Shuldman, David B Peters, Graham Y Tanaka, Steven A Demartino, Thomas R Schwarz and Tracey S Chernay. View Insider Buying and Selling for TransAct Technologies.

TACT stock was purchased by a variety of institutional investors in the last quarter, including Cowen Prime Services LLC, Wedge Capital Management L L P NC, North Star Investment Management Corp., LSV Asset Management, Connors Investor Services Inc. and Cable Hill Partners LLC. Company insiders that have bought TransAct Technologies stock in the last two years include Haydee Olinger and John Dillon. View Insider Buying and Selling for TransAct Technologies.

Shares of TACT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TACT stock can currently be purchased for approximately $11.57.

TransAct Technologies has a market capitalization of $86.31 million and generates $54.59 million in revenue each year. TransAct Technologies employs 126 workers across the globe.View Additional Information About TransAct Technologies.

The official website for TransAct Technologies is http://www.transact-tech.com/.

TransAct Technologies' mailing address is ONE HAMDEN CENTER 2319 WHITNEY AVENUE SUITE 3B, HAMDEN CT, 06518. The technology company can be reached via phone at 203-859-6800 or via email at [email protected]